Search research articles
Contact Us
Filters
Showing results (31-40 of 264) with videos related to
Page
of 27
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
August 20, 2016
A Goiter in Christ in Crucifixion
Paolo Pozzilli, Davide Lazzeri
Diabetes, Obesity & Metabolism
|
October 28, 2024
Financial incentives and public health with a focus on obesity: Turning point or dead end?
Paolo Pozzilli, Marco Sormani
Endocrine
|
January 2, 2014
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes)
Ernesto Maddaloni, Paolo Pozzilli
Endocrine
|
April 1, 2025
An estimated prevalence of goiter in the 15th century
Maria Vittoria Messina, Paolo Pozzilli
Expert Opinion on Pharmacotherapy
|
February 21, 2018
Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients
Anda Mihaela Naciu, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews
|
May 1, 2009
New prospects for immunotherapy at diagnosis of type 1 diabetes
Paolo Pozzilli, R David Leslie
Diabetes/Metabolism Research and Reviews
|
August 29, 2013
Do we need continuous glucose monitoring in type 2 diabetes?
Anna Rita Maurizi, Paolo Pozzilli
Diabetes Research and Clinical Practice
|
August 8, 2022
COVID-19 induced Diabetes: A novel presentation
Samruddhi Chandrashekhar Joshi, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews
|
May 8, 2002
Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes
Philip E Beales, Paolo Pozzilli
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
July 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Page
of 27
Search research articles
Search
Showing results (31-40 of 264) with videos related to
Sort By:
Page
of 27
Thyroid : Official Journal of the American Thyroid Association
|
August 20, 2016
A Goiter in Christ in Crucifixion
Paolo Pozzilli, Davide Lazzeri
Diabetes, Obesity & Metabolism
|
October 28, 2024
Financial incentives and public health with a focus on obesity: Turning point or dead end?
Paolo Pozzilli, Marco Sormani
Endocrine
|
January 2, 2014
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes)
Ernesto Maddaloni, Paolo Pozzilli
Endocrine
|
April 1, 2025
An estimated prevalence of goiter in the 15th century
Maria Vittoria Messina, Paolo Pozzilli
Expert Opinion on Pharmacotherapy
|
February 21, 2018
Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients
Anda Mihaela Naciu, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews
|
May 1, 2009
New prospects for immunotherapy at diagnosis of type 1 diabetes
Paolo Pozzilli, R David Leslie
Diabetes/Metabolism Research and Reviews
|
August 29, 2013
Do we need continuous glucose monitoring in type 2 diabetes?
Anna Rita Maurizi, Paolo Pozzilli
Diabetes Research and Clinical Practice
|
August 8, 2022
COVID-19 induced Diabetes: A novel presentation
Samruddhi Chandrashekhar Joshi, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews
|
May 8, 2002
Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes
Philip E Beales, Paolo Pozzilli
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
July 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Page
of 27